| 6 Einträge |
| Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial. | |
| Autoren | Martin M, Holmes FA, Ejlertsen B, Delaloge S, Moy B, Iwata H, von Minckwitz G, Chia SKL, Mansi J, Barrios CH, Gnant M, Tomašević Z, Denduluri N, Šeparović R, Gokmen E, Bashford A, Ruiz Borrego M, Kim SB, Jakobsen EH, Ciceniene A, Inoue K, Overkamp F, Heijns JB, Armstrong AC, Link JS, Joy AA, Bryce R, Wong A, Moran S, Yao B, Xu F, Auerbach A, Buyse M, Chan A |
| Erscheinungsdaten | The Lancet. Oncology. 2017 Nov 13. pii: S1470-2045(17)30717-9. doi: 10.1016/S1470-2045(17)30717-9 |
| Publikations ID | PMID: 29146401 |
| Treatment of Early Breast Cancer Patients: Evidence, Controversies, Consensus: Focusing on Systemic Therapy - German Experts' Opinions for the 16th International St. Gallen Consensus Conference (Vienna 2019). | |
| Autoren | Lüftner D, Bauerfeind I, Braun M, Brucker SY, Fasching PA, Felberbaum R, Hagemann F, Haidinger R, Harbeck N, Hönig A, Huober J, Jackisch C, Kolberg HC, Kolberg-Liedtke C, Kühn T, Maass N, Reimer T, Schneeweiss A, Schumacher-Wulf E, Schütz F, Thomssen C, Untch M, Wuerstlein R, Thill M |
| Erscheinungsdaten | Breast care (Basel, Switzerland). 2019 Sep 17. doi: 10.1159/000502603. pii: brc-0014-0315. pmc: PMC6883436 |
| Publikations ID | PMID: 31798392 |
| Recent Advances in Practical Methods for Liver Cell Biology: A Short Overview. | |
| Autoren | Torres S, Abdullah Z, Brol MJ, Hellerbrand C, Fernandez M, Fiorotto R, Klein S, Königshofer P, Liedtke C, Lotersztajn S, Nevzorova YA, Schierwagen R, Reiberger T, Uschner FE, Tacke F, Weiskirchen R, Trebicka J |
| Erscheinungsdaten | International journal of molecular sciences. 2020 Mar 16. pii: ijms21062027. doi: 10.3390/ijms21062027 |
| Publikations ID | PMID: 32188134 |
| Results from the FeDeriCa trial: are we reducing the burden of breast cancer treatment? | |
| Autoren | Bartsch R, Minichsdorfer C, Kolberg-Liedtke C |
| Erscheinungsdaten | The Lancet. Oncology. 2020 Dec 17. pii: S1470-2045(20)30636-7. doi: 10.1016/S1470-2045(20)30636-7 |
| Publikations ID | PMID: 33357419 |
| Expert Discussion: SABCS 2021. | |
| Autoren | Bartsch R, Kolberg-Liedtke C, Jerusalem G, Palmieri C, Janni W |
| Erscheinungsdaten | Breast care (Basel, Switzerland). 2022 Jan 4. doi: 10.1159/000521762. pii: brc-0017-0101. pmc: PMC8914229 |
| Publikations ID | PMID: 35355701 |
| Adjuvant denosumab in breast cancer (ABCSG-18): a multicentre, randomised, double-blind, placebo-controlled trial. | |
| Autoren | Gnant M, Pfeiler G, Dubsky PC, Hubalek M, Greil R, Jakesz R, Wette V, Balic M, Haslbauer F, Melbinger E, Bjelic-Radisic V, Artner-Matuschek S, Fitzal F, Marth C, Sevelda P, Mlineritsch B, Steger GG, Manfreda D, Exner R, Egle D, Bergh J, Kainberger F, Talbot S, Warner D, Fesl C, Singer CF |
| Erscheinungsdaten | Lancet (London, England). 2015 May 31. pii: S0140-6736(15)60995-3. doi: 10.1016/S0140-6736(15)60995-3 |
| Publikations ID | PMID: 26040499 |